Maravai LifeSciences

Forecast & Rating9 analysts currently cover Maravai LifeSciences, with about 55.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $7.42, about 6.8% upside from the current price of $6.95. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 30.6% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Maravai LifeSciences are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 9, 2026; for reference only and not investment advice.